Integrated Advisors Network’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $338K | Sell |
8,800
-914
| -9% | -$35.1K | 0.02% | 588 |
|
|
2025
Q1 | $376K | Buy |
9,714
+625
| +7% | +$24.2K | 0.02% | 524 |
|
|
2024
Q4 | $308K | Sell |
9,089
-2,876
| -24% | -$97.3K | 0.01% | 559 |
|
|
2024
Q3 | $489K | Sell |
11,965
-113
| -0.9% | -$4.62K | 0.02% | 470 |
|
|
2024
Q2 | $465K | Buy |
12,078
+381
| +3% | +$14.7K | 0.02% | 460 |
|
|
2024
Q1 | $502K | Buy |
11,697
+1,910
| +20% | +$81.9K | 0.03% | 457 |
|
|
2023
Q4 | $363K | Buy |
9,787
+1,265
| +15% | +$46.9K | 0.02% | 511 |
|
|
2023
Q3 | $309K | Sell |
8,522
-1
| -0% | -$36 | 0.02% | 521 |
|
|
2023
Q2 | $304K | Buy |
8,523
+66
| +0.8% | +$2.35K | 0.02% | 536 |
|
|
2023
Q1 | $301K | Buy |
8,457
+2,170
| +35% | +$77.2K | 0.02% | 544 |
|
|
2022
Q4 | $221K | Buy |
+6,287
| New | +$221K | 0.01% | 572 |
|
|
2022
Q3 | – | Sell |
-86,666
| Closed | -$4.72M | – | 668 |
|
|
2022
Q2 | $4.72M | Buy |
86,666
+20,126
| +30% | +$1.1M | 0.31% | 89 |
|
|
2022
Q1 | $3.62M | Buy |
66,540
+61,542
| +1,231% | +$3.35M | 0.21% | 122 |
|
|
2021
Q4 | $276K | Buy |
4,998
+300
| +6% | +$16.6K | 0.02% | 545 |
|
|
2021
Q3 | $224K | Buy |
+4,698
| New | +$224K | 0.01% | 564 |
|
|
2020
Q4 | – | Sell |
-4,829
| Closed | -$227K | – | 508 |
|
|
2020
Q3 | $227K | Sell |
4,829
-2,250
| -32% | -$106K | 0.03% | 397 |
|
|
2020
Q2 | $361K | Buy |
7,079
+2,172
| +44% | +$111K | 0.04% | 308 |
|
|
2020
Q1 | $232K | Sell |
4,907
-37
| -0.7% | -$1.75K | 0.05% | 319 |
|
|
2019
Q4 | $290K | Buy |
+4,944
| New | +$290K | 0.04% | 331 |
|